Government of Malaysia
Also known as: Department of Anaesthesia, Hospital Tengku Ampuan Rahimah, Ministry of Health, Malaysia | Government of Malaysia | Malaysia Palm Oil Board | Ministry of Education, Malaysia | Ministry of Energy, Science, Technology, Environment and Climate Change, Malaysia | Ministry of Health, Malaysia | Ministry of Science, Technology and Innovation, Malaysia | Ministry of Science, Technology and Innovation (MOSTI) Malaysia | National Pharmaceutical Regulatory Agency
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2001Last known activity
Jun 28, 2024
Timeline
1960s
- Jan 1, 1963
Government of Malaysia— Founded
Drugs by trial phase (61 distinct, 53 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Bronchiectasis
- Carcinoma
- Cardiovascular Diseases
- Cartilage Diseases
- Cerebrovascular Disorders
- Cognitive Dysfunction
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- End Stage Liver Disease
- Fatty Liver
- Glaucoma
- Glaucoma, Open-Angle
- Glucose Intolerance
- Graft vs Host Disease
- Graves Disease
- Hemorrhage
- Hepatitis C
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hypertension
- Hyperthyroidism
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Liver Diseases
- Long Term Adverse Effects
- Malaria
- Malaria, Vivax
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Non-alcoholic Fatty Liver Disease
- Ocular Hypertension
- Pelvic Neoplasms
- Postpartum Hemorrhage
- Prediabetic State
- Renal Insufficiency, Chronic
- Vascular Diseases
Recent trials (50)
- NCT06336824Sponsor investigatorPhase 3Jun 28, 2024
- NCT05977244Overall official - principal investigatorN/AMay 21, 2022
- NCT05977244Lead sponsorN/AMay 21, 2022
- NCT04920942Overall official - principal investigatorPhase 4Jun 1, 2021
- NCT04573218CollaboratorPhase 2Nov 30, 2020
- NCT04512196CollaboratorN/ASep 9, 2020
- NCT04164446CollaboratorPhase 1Dec 31, 2019
- NCT04161404CollaboratorPhase 1Aug 21, 2019
- NCT03888768Reponsible party - principal investigatorN/AJun 30, 2019
- NCT03888768Lead sponsorN/AJun 30, 2019
- NCT03855423CollaboratorN/AFeb 18, 2019
- NCT03847844CollaboratorPhase 1/Phase 2Feb 1, 2019
- NCT03532763Lead sponsorN/AApr 19, 2018
- NCT02532088CollaboratorPhase 2Aug 1, 2017
- NCT02358967CollaboratorN/AJun 1, 2017
Details
- Founded
- Kuala Lumpur, MY Jan 1, 1963
- Last known activity
- Jun 28, 2024